1 – 14 of 14
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Growth differentiation factor-15 and incident chronic kidney disease : a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Pro-Enkephalin and its association with renal function in Middle Eastern immigrants and native Swedes
(
- Contribution to journal › Article
- 2020
-
Mark
Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years
2020) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 35(2). p.265-273(
- Contribution to journal › Article
- 2019
-
Mark
Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
Plasma copeptin as a predictor of kidney disease
2019) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 34(1). p.74-82(
- Contribution to journal › Article
- 2018
-
Mark
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort
(
- Contribution to journal › Article
- 2017
-
Mark
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD
(
- Contribution to journal › Article
- 2016
-
Mark
Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population
(
- Contribution to journal › Article
-
Mark
Cystatin C and risk of diabetes and the metabolic syndrome - Biomarker and genotype association analyses
(
- Contribution to journal › Article
- 2015
-
Mark
Cystatin C Is Not Causally Related to Coronary Artery Disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Family History of Myocardial Infarction Increases Risk of Renal Dysfunction in Middle Age.
(
- Contribution to journal › Article
-
Mark
Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
(
- Contribution to journal › Article
- 2009
-
Mark
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.
(
- Contribution to journal › Article